Slide 1
Slide 2
Slide 3
Slide 4
Slide 5

Publications

Journal Papers

  1. 30. Early Immunological Biomarkers for Personalized Treatment Selection in Severe COVID 19: Post Hoc Machine Learning Analysis of a Randomized Clinical Trial.

    Savvopoulos, S., Papadopoulou, A., Karavalakis, G., Sakellari, I., Georgolopoulos, G., Argyropoulos, C., Yannaki, E., Hatzikirou, H.

  2. 29. Barriers and Opportunities to Include Underrepresented Population Groups in Vaccine Trials: Cross-Sectional, Observational, Online Survey Study From the VACCELERATE Research Network.

    Tanriover, M.D., Poulimeneas, D., Tsopela, G.-C., Kopsidas, I., Argyropoulos, C., Di Marzo, R., Valdenmaiier, O., Jakobsen, S.F., Valle Simon, P., Carcas-Sansuan, A.J., Olesen, O.F., Cornely, O.A., Pana, Z.D., Zaoutis, T., Akova, M.

  3. 28. Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project.

    Malik, S., Pana, Z.D., Argyropoulos, C.D., Themistocleous, S.C., Macken, A., Valdenmaiier, O., Scheckenbach, F., Bardach, E., Pfeiffer, A., Ochando, J. A., Cornely, O.A, Demotes, J., Contrino, S., Felder, G.

  4. 27. Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study.

    Themistocleous, S.C., Argyropoulos, C.D., Vogazianos, P., Shiamakkides, G., Noula, E., Nearchou, A., Yiallouris, A., Filippou, C. Stewart, F.A., Koniordou, M., Kopsidas, I., Askling, H.H., Vene, S., Gagneux-Brunon, A., Prellezo, J.B., Álvarez-Barco, E., Salmanton-García, J., Leckler, J., Macken, A., Davis, R.J., Azzini, A.M., Armeftis, C., Hellemans, M., Di Marzo, R., Luís, C., Olesen, O.F., Valdenmaiier, O., Jakobsen, S.F., Nauclér, P., Launay, O., Mallon, P., Ochando, J., van Damme, P., Tacconelli, E., Zaoutis, T.E., Cornely, O.A., Pana Z.D. on behalf of the VACCELERATE consortium.

  5. 26. Predicting the next pandemic: VACCELERATE ranking of the World health Organization's Blueprint for action to prevent epidemics.

    Salmanton-García J., Wipfler, P., Leckler, J., Nauclér, P., Mallon, P.W., Bruijning-Verhagen, P.C.J.L., Schmitt, H.-J., Bethe, U., Olesen, O.F., Stewart, F.A., Albus, K., Cornely, O.A., on behalf of the VACCELERATE Consortium, Busch, M., Seifert, U., Widmer, A., Nagao, M., Rello, J., Todorova, T., Cviljević, S., Heath, C.H., Jančorienė, L., Fischer, T.K., Orth, H.M., Johansen, I.S., Doymaz, M., Tragiannidis, A., Löscher, T., Xu J.-F., Husa, P., Oteo, J.A., Issack, M.I., Zeitlinger, M., Le Grand R., Zdziarski P., Demirkan, F., Amador, P.M., García-Lozano, T., Cao, Q., Vázquez, L., Caeiro, J.P., Hermans, P., Nahrwar, S., Avsar, K., Kumar, D., Fernández, N., Mardani, M., Segal, E., Pan, A., Gkentzi, D., Gioula, G., Cortés J.A., Oliveira, J., van Damme P, Bin M.Z., Antinori, S., Zablockienė, B., Papazisis, G., Aneke, C.I., Valerio, M., McConkey, S., Aujayeb, A., Azzini A.M., Roganović, J., Greve-Isdahl Mohn, K., Kremsner, P., Gkrania-Klotsas, E., Corzo, D., Khanna, N., Smiatacz, T., Scheithauer, S., Merelli, M., Klempa, B., Vrḫovac, R,. Ruggiero, A., Chaudhary, P., Maquera-Afaray, J., Ekkelenkamp, M., Jindra, P., Pantić, N., Guerra, G. J., Weiss, G., Roohi, B., Argyropoulos, C.D., Silfverda,l S.A., van Praet, J., Bal, Z.S., Kanj, S., Young, B., Pana, Z.D., Roilides, E., Stearns, S.C., Wauters, J., Baño, J.R., Pletz, M.W., Travar, M., Kühn, S., Riera, F., Cornely, D., Laura, V.J., Kohler, P., Eley, B., Nair, P.K., Ciesek, S., Olaru, I.D., Marques, L., Pontali, E., Naunheim, A., Lieb, A., Gerhard, M., Farooqi, J.Q., Turtle, L., Méndez, G.A., Cox, R.J., Goodman, N., Caceca, B., Pemán, J., Dawood, H., Askling, H.H., Fomsgaard, A, Hernández A. C., Staehelin, C., Liu, C.-Y., Icardi, G., Castagnola, E., Salzer, H.J.F., Lundgren, J., Javadli, S., Forghieri, F.

  6. 25. Challenges of vaccine trial participation among underserved and hard-to-reach communities: an internal expert consultation of the VACCELERATE consortium.

    Poulimeneas, D., Koniordou, M., Kousi, D., Merakou, C., Kopsidas, I., Tsopela, G.C., Argyropoulos, C.D., Themistocleous, S.C., Shiamakkides, G., Constantinou, M., Alexandrou, A., Noula, E., Nearchou, A., Salmanton-García, J., Stewart, F.A., Heringer, S., Albus, K., Álvarez-Barco, E., Macken, A., Di Marzo, R., Luis, C., Valle-Simón, P., Askling, H.H., Hellemans, M., Spivak, O., Davis, R.J., Azzini, A.M., Barta, I., Součková, L., Jancoriene, L., Akova, M., Mallon, P.W.G., Olesen, O.F., Frias-Iniesta, J., Van Damme, P., Tóth, K., Cohen-Kandli, M., Cox, R.J., Husa, P., Nauclér, P., Marques, L., Ochando, J., Tacconelli, E., Zeitlinger, M., Cornely, O.A., Pana, Z.D. and Zaoutis, T.E.

  7. 24. VACCELERATE Site Network: Real-Time Definition of Clinical Study Capacity in Europe.

    Salmanton-García, J., Wipfler, P., Valle-Simón, P., Merakou, C., Kopsidas, I., Bethe, U., Steinbach, A., Spivak, O., Součková, L., Mendonça, M.A., Koniordou, M., Hellemans, M., Frías-Iniesta, J., Davis, R.J., Barta, I., Azzini, A.M., Askling, H.H., Argyropoulos, C.D., Álvarez-Barco, E., Akova, M., Bonten, M.M.J., Cohen-Kandli, M., Cox, R.J., Flisiak, R., Husa, P., Jancoriene, L., Koscalova, A., Launay, O., Lundgren, J., Mallon, P., Marques, L., Nauclér, P., Ochando, J., Pana, Z.D., Tacconelli, E., Tóth, K., Trelle, S., Damme, P., Zaoutis, T.E., Zeitlinger, M., Albus, K., Stewart, F.A., Hofstraat, S.H.I., Bruijning, P., Cornely, O.A.

  8. 23. Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit.

    Argyropoulos, C.D., Leckler, J., Salmanton-García, J., Constantinou, M., Alexandrou, A., Themistocleous, S.C., Noula, E., Shiamakkides, G., Nearchou, A., Stewart, F.A., Albus, K., Koniordou, M., Kopsidas, I., Spivak, O., Hellemans, M., Davis, R.J., Azzini, A.M., Valle-Simón, P., Carcas, A.J., Askling, H.H., Vene, S., Prellezo, J.B., Álvarez-Barco, E., Macken, A., Anderson, Y., Di Marzo, R., Luís, C., Olesen, O.F., Frias-Iniesta, J., Barta, I., Akova, M., Bonten, M.M.J., Cohen-Kandli, M., Cox, R.J., Flisiak, R., Součková, L., Husa, P., Jancoriene, L., Koscalova, A., Launay, O., Lundgren, J., Mallon, P., Armeftis, C., Marques, L., Nauclér, P., Ochando, J., Tacconelli, E., Tóth, K., Trelle, S., van Damme, P., Zaoutis, T.E., Hofstraat, S.H.I., Bruijning, P., Zeitlinger, M., Cornely, O.A., Pana, Z.D.

  9. 22. Airborne transmission of chemical and biological agents into indoor build environment: A multidisciplinary review.

    Argyropoulos, C.D., Efthimiou, G., Skoulou, V., Michopoulos, A.

  10. 21. Vaccination rates in Europe are not associated with online media intensity.

    Luis, C., Di Marzo, V.R., Kaur, M., Argyropoulos, C.D., Devane, D., Stewart, F.A., Antoniou, G., Hendrickx, G., Askling, H.H., Hellemans, M., Cohen, M., Spivak, O., Van Damme, P., Cox, R.J., Vene, S., Sibia, S., Pana, Z.D., Olesen, O.F.

  11. 20. VACCELERATE Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment.

    Salmanton-García, J., Stewart, F.A., Heringer, S., Koniordou, M., Álvarez-Barco, E., Argyropoulos, C.D., Themistocleous, S., Valle-Simón, P., Spivak, O., Součková, L., Merakou, C., Mendonça, M.A., Davis, R. J., Azzini, A.M., Askling, H. H., Vene, S., Van Damme, P., Steinbach, A., Shiamakkides, G., Seidel, D., Olesen, O.F., Noula, E., Macken, A., Luís, C., Leckler, J., Launay, O., Isitt, C., Hellemans, M., Frías, J., Carcas, A.J., Boustras, G., Borobia, A.M., Barta, I., Albus, K., Akova, M., Ochando, J., Cohen-Kandli, M., Cox, R., Husa, P., Jancoriene, L., Mallon, P., Marques, L., Mellinghoff, S., Nauclér, P., Tacconelli, E., Tóth, K., Zaoutis, T.E., Zeitlinger, M., Cornely, O.A., Pana, Z.D and consortium of the VACCELERATE.

  12. 19. Impact of weak signals on the digitalization of risk analysis in process safety operational environments.

    Benson, C., Argyropoulos, C.D., Nicolaidou, G, Boustras, G.

  13. 18. Analysis of safety climate factors and safety compliance relationships in the oil and gas industry.

    Benson, C., Argyropoulos, C.D., Dimopoulos, C., Varianou-Mikellidou, C., Boustras, G.

  14. 17. Impact assessment of COVID-19 non-pharmaceutical interventions in long term care facilities in Cyprus: safety improvement strategy.

    Vogazianos, P., Argyropoulos, C.D., Haralambous, C., Varianou-Mikellidou, C., Boustras, G., Andreou, M., Silvestros, V., Theofanous, F., Soteriou, S., Gregoriou, I., Apostolidou, A.J., Demetriou, A., Athanasiadou, M., Stylianou, C., Michael, M., Herodotou, H., Alexandrou, D., Kalakouta, O., M., Pana, Z.D.

  15. 16. Assessing the common occupational health hazards and their health risks among oil and gas workers.

    Benson, C., Dimopoulos, C., Argyropoulos, C.D., Varianou-Mikellidou, C., Boustras, G.

  16. 15. Safety and risk analysis in digitalized process operations warning of possible deviating conditions in the process environment.

    Benson, C., Argyropoulos, C.D., Dimopoulos, C., Varianou-Mikellidou, C., Boustras, G.

  17. 14. Measurements and modelling of particulate matter building ingress during severe dust storms events.

    Argyropoulos, C.D., Hassan, H., Kumar, P., Kakosimos, K.E.

  18. 13. Implicit definition of flow patterns in street canyons – recirculation zone – using exploratory quantitative and qualitative methods.

    Chatzimichailidis, A., Argyropoulos, C.D., Assael, M., Kakosimos, K.E.

  19. 12. Qualitative and quantitative investigation of multiple Large Eddy Simulation aspects for pollutant dispersion in street canyons using OpenFOAM.

    Chatzimichailidis, A., Argyropoulos, C.D., Assael, M., Kakosimos, K.E.

  20. 11. Evaluation of an inverse modelling methodology for the prediction of the location and strength of a point source releasing airborne material in two complex urban environments.

    Efthimiou, G.C., Kovalets, I.V., Argyropoulos, C.D., Venetsanos, A.G., Andronopoulos, S., Kakosimos, K.E. (2018).

  21. 10. Source reconstruction of airborne toxics based on acute health effects information.

    Argyropoulos, C.D., Elkhalifa, S., Fthenou, E., Efthimiou, G.C., Andronopoulos, S., Venetsanos, A., Kovalets, I.V., Kakosimos, K.E. (2018)

  22. 9. Inverse identification of unknown finite-duration air pollutant release from a point source in urban environment.

    Kovalets, I.V., Efthimiou, G.C., Andronopoulos, S., Venetsanos, A.G., Argyropoulos, C.D., Kakosimos, K.E.

  23. 8. An optimized inverse method for the source determination of an airborne material released from a point source in an urban environment.

    Efthimiou, G.C., Andronopoulos, S., Kovalets, I.V., Venetsanos, A., Argyropoulos, C.D., Kakosimos, K.E.

  24. 7. Mathematical modelling and computer simulation of toxic gas building infiltration.

    Argyropoulos, C.D., Ashraf, A.M., Kakosimos, K.E., Markatos N.C.

  25. 6. Recent advances on the numerical modelling of turbulent flows.

    Argyropoulos, C.D. and Markatos, N.C.

  26. 5. A hazards assessment methodology for large liquid hydrocarbon fuel tanks.

    Argyropoulos, C.D., Christolis, M.N., Nivolianitou, Z., Markatos, N.C.

  27. 4. High Reynolds number turbulent flow past a rotating cylinder.

    Karabelas, S.J., Koumroglou, B.C., Argyropoulos, C.D., Markatos, N.C.

  28. 3. A methodology for the hazard assessment in large hydrocarbon fuel tanks.

    Nivolianitou Z.S., Argyropoulos C.D., Christolis, M.N., Markatos, N.C.

    Chemical Engineering Transactions (2012) 26, 171-176.

  29. 2. Modelling pollutants dispersion and plume rise from large hydrocarbon tank fires in neutrally stratified atmosphere.

    Argyropoulos, C.D., Sideris, G.M., Christolis, M.N., Nivolianitou, Z., Markatos, N.C.

  30. 1. Mathematical modelling of toxic pollutants dispersion from large tank fires and assessment of acute effects for fire fighters.

    Markatos, N.C., Christolis, M.N., Argyropoulos, C.D.